Biosys Health - Biological Immune Care
Biosys Health has developed two proprietary platforms that protect and support the mucosal and Gastroinstestinal (GI) tract for a balanced, effective and healthy immune response.
- Platform 1: Natural antibody (Ab) therapy that re-establishes a balanced microbiome across the GI tract
- Lead program: C difficile Associated Diarrhoea, registration study to start 2017
- Platform 2: Chitin microparticles to modify immune response and provide enhanced barrier protection
- Lead program: Inflammatory Bowel Disease, registration study to start 2017